Adjuvant hepatic arterial infusion pump chemotherapy with floxuridine for patients with resectable colorectal liver metastases and a low clinical risk score: A randomized controlled trial—The PUMP trial.
Loubna Outmani(Utrecht University), Bas Groot Koerkamp(Erasmus MC Cancer Institute), Pascal G. Doornebosch(IJsselland Ziekenhuis), Jan Willem de Groot(Isala), Paul D. Gobardhan(Amphia Ziekenhuis), Karen Bolhuis(The Netherlands Cancer Institute), Leni van Doorn(Erasmus MC), Dirk J. Grünhagen(Erasmus MC), Jeroen Hagendoorn(Utrecht University), N. Kok(Oncode Institute), Koert Kuhlmann(Dutch Cancer Society), C Verhoef(Erasmus MC Cancer Institute), Florian Buisman(Erasmus MC), Joost van der Hoeven(Albert Schweitzer Ziekenhuis), J. Sven D. Mieog(Leiden University Medical Center), Rutger-Jan Swijnenburg(Vrije Universiteit Amsterdam), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Maarten Vermaas(Association of British Orchestras), Wills Floris Filipe(Erasmus MC), Karolina Sikorska(Dutch Cancer Society)
Cited by 2
Related Papers
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
|The Lancet Oncology|2018|582
Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)
|British journal of surgery|2015|195
Total Pelvic Exenteration for Primary and Recurrent Malignancies
|World Journal of Surgery|2009|193